Report cover image

Global DTIs for Injection Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 208 Pages
SKU # APRC20283186

Description

Summary

According to APO Research, The global DTIs for Injection market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for DTIs for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for DTIs for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for DTIs for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for DTIs for Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of DTIs for Injection include Yangtze River Pharmaceutical, Beijing SL Pharmaceutical, CSPC Ouyi Pharmaceutical, Lunan Pharmaceutical, BrightGene, The Medicines Company, Teva Pharmaceutical, Sandoz and Pfizer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for DTIs for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of DTIs for Injection, also provides the sales of main regions and countries. Of the upcoming market potential for DTIs for Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the DTIs for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global DTIs for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for DTIs for Injection sales, projected growth trends, production technology, application and end-user industry.

DTIs for Injection Segment by Company

Yangtze River Pharmaceutical
Beijing SL Pharmaceutical
CSPC Ouyi Pharmaceutical
Lunan Pharmaceutical
BrightGene
The Medicines Company
Teva Pharmaceutical
Sandoz
Pfizer
Mitsubishi Tanabe Pharma
GlaxoSmithKline
Eugia Pharma
Dr.Reddy's Laboratories
Aurobindo Pharma
Apotex
Accord Healthcare
DTIs for Injection Segment by Type

Argatroban
Bivalirudin
Other
DTIs for Injection Segment by Application

Pulmonary Embolism
Deep Vein Thrombosis
Atrial Fibrillation
Other
DTIs for Injection Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DTIs for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DTIs for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DTIs for Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of DTIs for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of DTIs for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DTIs for Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

208 Pages
1 Market Overview
1.1 Product Definition
1.2 DTIs for Injection Market by Type
1.2.1 Global DTIs for Injection Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Argatroban
1.2.3 Bivalirudin
1.2.4 Other
1.3 DTIs for Injection Market by Application
1.3.1 Global DTIs for Injection Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pulmonary Embolism
1.3.3 Deep Vein Thrombosis
1.3.4 Atrial Fibrillation
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 DTIs for Injection Market Dynamics
2.1 DTIs for Injection Industry Trends
2.2 DTIs for Injection Industry Drivers
2.3 DTIs for Injection Industry Opportunities and Challenges
2.4 DTIs for Injection Industry Restraints
3 Global Market Growth Prospects
3.1 Global DTIs for Injection Revenue Estimates and Forecasts (2020-2031)
3.2 Global DTIs for Injection Revenue by Region
3.2.1 Global DTIs for Injection Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global DTIs for Injection Revenue by Region (2020-2025)
3.2.3 Global DTIs for Injection Revenue by Region (2026-2031)
3.2.4 Global DTIs for Injection Revenue Market Share by Region (2020-2031)
3.3 Global DTIs for Injection Sales Estimates and Forecasts 2020-2031
3.4 Global DTIs for Injection Sales by Region
3.4.1 Global DTIs for Injection Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global DTIs for Injection Sales by Region (2020-2025)
3.4.3 Global DTIs for Injection Sales by Region (2026-2031)
3.4.4 Global DTIs for Injection Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global DTIs for Injection Revenue by Manufacturers
4.1.1 Global DTIs for Injection Revenue by Manufacturers (2020-2025)
4.1.2 Global DTIs for Injection Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global DTIs for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global DTIs for Injection Sales by Manufacturers
4.2.1 Global DTIs for Injection Sales by Manufacturers (2020-2025)
4.2.2 Global DTIs for Injection Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global DTIs for Injection Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global DTIs for Injection Sales Price by Manufacturers (2020-2025)
4.4 Global DTIs for Injection Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global DTIs for Injection Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global DTIs for Injection Manufacturers, Product Type & Application
4.7 Global DTIs for Injection Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global DTIs for Injection Market CR5 and HHI
4.8.2 2024 DTIs for Injection Tier 1, Tier 2, and Tier 3
5 DTIs for Injection Market by Type
5.1 Global DTIs for Injection Revenue by Type
5.1.1 Global DTIs for Injection Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global DTIs for Injection Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global DTIs for Injection Revenue Market Share by Type (2020-2031)
5.2 Global DTIs for Injection Sales by Type
5.2.1 Global DTIs for Injection Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global DTIs for Injection Sales by Type (2020-2031) & (K Units)
5.2.3 Global DTIs for Injection Sales Market Share by Type (2020-2031)
5.3 Global DTIs for Injection Price by Type
6 DTIs for Injection Market by Application
6.1 Global DTIs for Injection Revenue by Application
6.1.1 Global DTIs for Injection Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global DTIs for Injection Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global DTIs for Injection Revenue Market Share by Application (2020-2031)
6.2 Global DTIs for Injection Sales by Application
6.2.1 Global DTIs for Injection Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global DTIs for Injection Sales by Application (2020-2031) & (K Units)
6.2.3 Global DTIs for Injection Sales Market Share by Application (2020-2031)
6.3 Global DTIs for Injection Price by Application
7 Company Profiles
7.1 Yangtze River Pharmaceutical
7.1.1 Yangtze River Pharmaceutical Comapny Information
7.1.2 Yangtze River Pharmaceutical Business Overview
7.1.3 Yangtze River Pharmaceutical DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Yangtze River Pharmaceutical DTIs for Injection Product Portfolio
7.1.5 Yangtze River Pharmaceutical Recent Developments
7.2 Beijing SL Pharmaceutical
7.2.1 Beijing SL Pharmaceutical Comapny Information
7.2.2 Beijing SL Pharmaceutical Business Overview
7.2.3 Beijing SL Pharmaceutical DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Beijing SL Pharmaceutical DTIs for Injection Product Portfolio
7.2.5 Beijing SL Pharmaceutical Recent Developments
7.3 CSPC Ouyi Pharmaceutical
7.3.1 CSPC Ouyi Pharmaceutical Comapny Information
7.3.2 CSPC Ouyi Pharmaceutical Business Overview
7.3.3 CSPC Ouyi Pharmaceutical DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 CSPC Ouyi Pharmaceutical DTIs for Injection Product Portfolio
7.3.5 CSPC Ouyi Pharmaceutical Recent Developments
7.4 Lunan Pharmaceutical
7.4.1 Lunan Pharmaceutical Comapny Information
7.4.2 Lunan Pharmaceutical Business Overview
7.4.3 Lunan Pharmaceutical DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Lunan Pharmaceutical DTIs for Injection Product Portfolio
7.4.5 Lunan Pharmaceutical Recent Developments
7.5 BrightGene
7.5.1 BrightGene Comapny Information
7.5.2 BrightGene Business Overview
7.5.3 BrightGene DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 BrightGene DTIs for Injection Product Portfolio
7.5.5 BrightGene Recent Developments
7.6 The Medicines Company
7.6.1 The Medicines Company Comapny Information
7.6.2 The Medicines Company Business Overview
7.6.3 The Medicines Company DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 The Medicines Company DTIs for Injection Product Portfolio
7.6.5 The Medicines Company Recent Developments
7.7 Teva Pharmaceutical
7.7.1 Teva Pharmaceutical Comapny Information
7.7.2 Teva Pharmaceutical Business Overview
7.7.3 Teva Pharmaceutical DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Teva Pharmaceutical DTIs for Injection Product Portfolio
7.7.5 Teva Pharmaceutical Recent Developments
7.8 Sandoz
7.8.1 Sandoz Comapny Information
7.8.2 Sandoz Business Overview
7.8.3 Sandoz DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Sandoz DTIs for Injection Product Portfolio
7.8.5 Sandoz Recent Developments
7.9 Pfizer
7.9.1 Pfizer Comapny Information
7.9.2 Pfizer Business Overview
7.9.3 Pfizer DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Pfizer DTIs for Injection Product Portfolio
7.9.5 Pfizer Recent Developments
7.10 Mitsubishi Tanabe Pharma
7.10.1 Mitsubishi Tanabe Pharma Comapny Information
7.10.2 Mitsubishi Tanabe Pharma Business Overview
7.10.3 Mitsubishi Tanabe Pharma DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Mitsubishi Tanabe Pharma DTIs for Injection Product Portfolio
7.10.5 Mitsubishi Tanabe Pharma Recent Developments
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Comapny Information
7.11.2 GlaxoSmithKline Business Overview
7.11.3 GlaxoSmithKline DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 GlaxoSmithKline DTIs for Injection Product Portfolio
7.11.5 GlaxoSmithKline Recent Developments
7.12 Eugia Pharma
7.12.1 Eugia Pharma Comapny Information
7.12.2 Eugia Pharma Business Overview
7.12.3 Eugia Pharma DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Eugia Pharma DTIs for Injection Product Portfolio
7.12.5 Eugia Pharma Recent Developments
7.13 Dr.Reddy's Laboratories
7.13.1 Dr.Reddy's Laboratories Comapny Information
7.13.2 Dr.Reddy's Laboratories Business Overview
7.13.3 Dr.Reddy's Laboratories DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Dr.Reddy's Laboratories DTIs for Injection Product Portfolio
7.13.5 Dr.Reddy's Laboratories Recent Developments
7.14 Aurobindo Pharma
7.14.1 Aurobindo Pharma Comapny Information
7.14.2 Aurobindo Pharma Business Overview
7.14.3 Aurobindo Pharma DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Aurobindo Pharma DTIs for Injection Product Portfolio
7.14.5 Aurobindo Pharma Recent Developments
7.15 Apotex
7.15.1 Apotex Comapny Information
7.15.2 Apotex Business Overview
7.15.3 Apotex DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Apotex DTIs for Injection Product Portfolio
7.15.5 Apotex Recent Developments
7.16 Accord Healthcare
7.16.1 Accord Healthcare Comapny Information
7.16.2 Accord Healthcare Business Overview
7.16.3 Accord Healthcare DTIs for Injection Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Accord Healthcare DTIs for Injection Product Portfolio
7.16.5 Accord Healthcare Recent Developments
8 North America
8.1 North America DTIs for Injection Market Size by Type
8.1.1 North America DTIs for Injection Revenue by Type (2020-2031)
8.1.2 North America DTIs for Injection Sales by Type (2020-2031)
8.1.3 North America DTIs for Injection Price by Type (2020-2031)
8.2 North America DTIs for Injection Market Size by Application
8.2.1 North America DTIs for Injection Revenue by Application (2020-2031)
8.2.2 North America DTIs for Injection Sales by Application (2020-2031)
8.2.3 North America DTIs for Injection Price by Application (2020-2031)
8.3 North America DTIs for Injection Market Size by Country
8.3.1 North America DTIs for Injection Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America DTIs for Injection Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America DTIs for Injection Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe DTIs for Injection Market Size by Type
9.1.1 Europe DTIs for Injection Revenue by Type (2020-2031)
9.1.2 Europe DTIs for Injection Sales by Type (2020-2031)
9.1.3 Europe DTIs for Injection Price by Type (2020-2031)
9.2 Europe DTIs for Injection Market Size by Application
9.2.1 Europe DTIs for Injection Revenue by Application (2020-2031)
9.2.2 Europe DTIs for Injection Sales by Application (2020-2031)
9.2.3 Europe DTIs for Injection Price by Application (2020-2031)
9.3 Europe DTIs for Injection Market Size by Country
9.3.1 Europe DTIs for Injection Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe DTIs for Injection Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe DTIs for Injection Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China DTIs for Injection Market Size by Type
10.1.1 China DTIs for Injection Revenue by Type (2020-2031)
10.1.2 China DTIs for Injection Sales by Type (2020-2031)
10.1.3 China DTIs for Injection Price by Type (2020-2031)
10.2 China DTIs for Injection Market Size by Application
10.2.1 China DTIs for Injection Revenue by Application (2020-2031)
10.2.2 China DTIs for Injection Sales by Application (2020-2031)
10.2.3 China DTIs for Injection Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia DTIs for Injection Market Size by Type
11.1.1 Asia DTIs for Injection Revenue by Type (2020-2031)
11.1.2 Asia DTIs for Injection Sales by Type (2020-2031)
11.1.3 Asia DTIs for Injection Price by Type (2020-2031)
11.2 Asia DTIs for Injection Market Size by Application
11.2.1 Asia DTIs for Injection Revenue by Application (2020-2031)
11.2.2 Asia DTIs for Injection Sales by Application (2020-2031)
11.2.3 Asia DTIs for Injection Price by Application (2020-2031)
11.3 Asia DTIs for Injection Market Size by Country
11.3.1 Asia DTIs for Injection Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia DTIs for Injection Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia DTIs for Injection Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA DTIs for Injection Market Size by Type
12.1.1 SAMEA DTIs for Injection Revenue by Type (2020-2031)
12.1.2 SAMEA DTIs for Injection Sales by Type (2020-2031)
12.1.3 SAMEA DTIs for Injection Price by Type (2020-2031)
12.2 SAMEA DTIs for Injection Market Size by Application
12.2.1 SAMEA DTIs for Injection Revenue by Application (2020-2031)
12.2.2 SAMEA DTIs for Injection Sales by Application (2020-2031)
12.2.3 SAMEA DTIs for Injection Price by Application (2020-2031)
12.3 SAMEA DTIs for Injection Market Size by Country
12.3.1 SAMEA DTIs for Injection Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA DTIs for Injection Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA DTIs for Injection Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 DTIs for Injection Value Chain Analysis
13.1.1 DTIs for Injection Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 DTIs for Injection Production Mode & Process
13.2 DTIs for Injection Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 DTIs for Injection Distributors
13.2.3 DTIs for Injection Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.